Similar Posts
The Hepatitis C Epidemic in One Picture
ByadminHepatitis C has been in the news lately, because of amazing (and amazingly expensive) new treatments that promise to cure their life-threatening illness. While we ought to debate the expense of these treatments, we should also remind ourselves of how much we’ve been spending caring for patients with advanced disease. Here’s a picture showing the…
Free to be Obese?
ByadminA short video showing why our eating decisions are often not conscious, or wise.
In this video, part of a webcast being organized by Fuqua, I lay out some thoughts on the psychology of obesity. Check it out. I’ll post a Q and A video on this topic (with the Qs provided by Fuqua alums) in a couple weeks. Feel free to add your questions in the meantime, and I’ll try to cover them too!Are Your Healthcare Prices Outrageous? Here's What Happens When Prices Come Out Of The Dark
ByadminThey both had shoulder pain, persistent despite weeks of physical therapy. Both received MRI examinations at reputable radiology facilities, looking for things like rotator cuff tears, labral disruptions and other anatomical abnormalities. What was different was the price they paid for the MRI, with one patient paying $1000 more than the other. Welcome to the…
Insurers Are Not Paying Enough For HPV Vaccines – And Our Kids Are Paying The Price
ByadminThe HPV vaccine saves lives. It does so by reducing a person’s chance of being infected by the human papilloma virus, a virus that causes a whole range of cancers including, most importantly, cervical cancer. Vaccinate your teenage daughter against HPV, and you will increase the chance she will live to old age. Simple as…
CASES: When Bad Advice Is the Best Advice
Byadmin“CASES: When Bad Advice Is the Best Advice” – The New York Times
Copay Assistance Controversy Continues
ByadminMy article with Peter Bach of Memorial Sloan Kettering continues to generate debate. The two of us argues that copay assistance programs from pharmaceutical companies help specific patients in the short run, but make it easier for drug companies to demand high prices for their products. Here is one take on the topic, spurred on…